Skip to main content

Advertisement

SpringerLink
Log in

Pediatric Lymphoma Diagnosis: Role of FNAC, Biopsy, Immunohistochemistry and Molecular Diagnostics

  • Symposium on Pediatric Oncology: Hemato-oncology
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Peripheral lymphadenopathy in the pediatric age group is screened using fine needle aspiration cytology (FNAC). Cases found to have features suspicious for lymphoma on FNAC need to undergo biopsy with immunohistochemistry for characterization and typing. In pediatric age group, peripheral lymph nodes are common in Hodgkin’s lymphoma for which biopsy is needed for subtyping. Distinction of classical Hodgkin’s lymphoma of lymphocyte rich type from nodular lymphocyte predominant Hodgkin’s lymphoma needs biopsy evaluation and a panel of immunostains. T lymphoblastic lymphomas and Burkitt’s lymphoma are the common types of non Hodgkin’s lymphoma seen in the pediatric age group. All lymphomas require a biopsy evaluation with immunohistochemistry and analysis of molecular genetic markers for proper characterization and selection of optimal treatment which are discussed in detail in this review.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organization Classification of Tumors. In: Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. Pathology and Genetics: Tumors of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001.

  2. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al. WHO Classification of Tumors of Haemopoietic and Lymphoid Tissues. Lyon: IARC Press; 2008.

    Google Scholar 

  3. Swaminathan R, Rama R, Shanta V. Childhood cancers in Chennai, India, 1990–2001: Incidence and survival. Int J Cancer. 2008;122:2607–11.

    Google Scholar 

  4. Gatta G, Capocaccia R, Stiller C, Kaatsch P, Berrino F, Terenziani M; the EUROCARE Working Group. Childhood cancer survival trends in Europe: A EUROCARE Working Group study. J Clin Oncol. 2005;23:3742–51.

    Google Scholar 

  5. Joy MP, Iyer VK, Aron M, Kapila K, Verma K. Rapid staining using toluidine blue: A reliable method for quick diagnosis in ultrasound-guided aspiration cytology. Indian J Pathol Microbiol. 2003;46:589–92.

    Google Scholar 

  6. Das P, Iyer VK, Mathur SR, Ray R. Anaplastic large cell lymphoma: A critical evaluation of cytomorphological features in seven cases. Cytopathology. 2010;21:251–8.

    Google Scholar 

  7. Jindal B, Agarwala S, Bakhshi S, Jain V, Gupta AK, Kumar R, et al. Bilateral primary renal lymphoma with orbital metastasis in a child. Pediatr Blood Cancer. 2009;52:539–41.

    Article  PubMed  Google Scholar 

  8. Rubnitz JE, Crist WM. Molecular genetics of childhood cancer: Implications for pathogenesis, diagnosis, and treatment. Pediatrics. 1997;100:101–8.

    Google Scholar 

  9. Tiemann M, Claviez A, Lüders H, Zimmermann M, Schellong G, Dörffel W, et al. Proliferation characteristics in pediatric Hodgkin’s lymphoma point to a cell cycle arrest in the G(1) phase. Mod Pathol. 2005;18:1440–7.

    Article  PubMed  CAS  Google Scholar 

  10. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–82.

    Article  PubMed  CAS  Google Scholar 

  11. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphomaidentified by gene expression profiling. Nature. 2000;403:503–11.

    Article  PubMed  CAS  Google Scholar 

  12. Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med. 2002;8:68–74.

    Article  PubMed  CAS  Google Scholar 

  13. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937–47.

    Article  PubMed  Google Scholar 

  14. Hummel M, Bentink S, Berger H, Klapper W, Wessendorf S, Barth TF, et al. A biological definition of Burkitt’s lymphoma from transcriptional and genomic profiling. N Engl J Med. 2006;354:2419–30.

    Article  PubMed  CAS  Google Scholar 

  15. Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, et al. Molecular diagnosis of Burkitt’s lymphoma. N Engl J Med. 2006;354:2431–42.

    Article  PubMed  CAS  Google Scholar 

  16. Sup SJ, Alemañy CA, Pohlman B, Elson P, Malhi S, Thakkar S, et al. His. Expression of bcl-2 in classical Hodgkin’s lymphoma: An independent predictor of poor outcome. J Clin Oncol. 2005;23:3773–9.

    Google Scholar 

  17. Kim LH, Peh SC, Poppema S. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: Relationship with expression of P53 and presence of Epstein–Barr virus in the regulation of cell growth and death. Hum Pathol. 2006;37:92–100.

    Google Scholar 

  18. Lossos IS, Jones KD, Warnke R, Natkunam Y, Kaizer H, Zehnder JL, et al. The expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma. Blood. 2001;98:945–51.

    Article  PubMed  CAS  Google Scholar 

  19. Lossos IS, Morgensztern D. Prognostic biomarkers in diffuse large B-cell lymphoma. J Clin Oncol. 2006;24:995–1007.

    Article  PubMed  CAS  Google Scholar 

  20. Gascoyne RD. Emerging prognostic factors in diffuse large B cell lymphoma. Curr Opin Oncol. 2004;16:436–41.

    Article  PubMed  Google Scholar 

  21. Mournier N, Briere J, Gisselbreacht C, Emile JF, Lederlin P, Sebban C, et al. Rituximab plus CHOP (R-CHOP) overcomes bcl-2 associated reststance to chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL). Blood. 2003;101:4279–84.

    Article  Google Scholar 

  22. Wilson KS, Sehn LH, Berry B, Chhanabhai M, Fitzgerald CA, Gill KK, et al. CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma. Leuk Lymphoma. 2007;48:1102–9.

    Article  PubMed  CAS  Google Scholar 

  23. Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, et al. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood. 2000;96:1921–5.

    PubMed  CAS  Google Scholar 

  24. Schlette EJ, Medeiros LJ, Goy A, Lai R, Rassidakis GZ. Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma. J Clin Oncol. 2004;22:1682–8.

    Article  PubMed  CAS  Google Scholar 

  25. Podar K, Anderson KC. The pathophysiologic role of VEGF in hematologic malignancies: Therapeutic implications. Blood. 2005;105:1383–95.

    Google Scholar 

  26. Iyer VK, Raina V, Dawar R. Prognostic utility of silver stained nucleolar organiser region counting in non Hodgkin’s lymphoma. Indian J Cancer. 2000;37:140–7.

    PubMed  CAS  Google Scholar 

  27. Moorthy G, Agarwala S, Sharma A, Iyer VK, Srinivas M, Bajpai M, et al. Cytogenetic evaluation of neuroblastoma using fine needle aspiration cultures. Pediatr Surg Int. 2009;25:939–43.

    Article  PubMed  CAS  Google Scholar 

  28. Ensani F, Mehravan S, Irvanlou G, Aghaipoor M, Vaeli S, Hajati E, et al. Fine needle aspiration cytology and flow cytometric immunophenotyping in diagnosis and classification of non-Hodgkin lymphoma in comparison to histopathology. Diagn Cytopathol. 2012;40:305–10.

    Article  PubMed  Google Scholar 

  29. Hay A, Pai I, Pitkin L, Williamson P, Wilson P, Deery A. Value of fine needle aspiration cytology in head and neck lymphoma: Experience in a head and neck cancer unit in the United Kingdom. Acta Otolaryngol. 2011;131:1226–31.

    Google Scholar 

  30. Barrena S, Almeida J, Del Carmen García-Macias M, López A, Rasillo A, Sayagués JM, et al. Flow cytometry immunophenotyping of fine needle aspiration specimens: Utility in the diagnosis and classification of non-Hodgkin lymphomas. Histopathology. 2011;58:906–18.

    Google Scholar 

Download references

Conflict of Interest

None.

Role of Funding Source

None.

Author information

Authors and Affiliations

  1. Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India

    Venkateswaran K. Iyer

Authors
  1. Venkateswaran K. Iyer
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Venkateswaran K. Iyer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iyer, V.K. Pediatric Lymphoma Diagnosis: Role of FNAC, Biopsy, Immunohistochemistry and Molecular Diagnostics. Indian J Pediatr 80, 756–763 (2013). https://doi.org/10.1007/s12098-013-1128-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12098-013-1128-2

Keywords

Search

Navigation